Search research articles
Contact Us
Filters
Showing results (21-30 of 57) with videos related to
Page
of 6
Sort By:
Annals of Surgical Oncology
|
May 10, 2021
Management of Soft Tissue Sarcomas in Extremities: Variation in Treatment Recommendations and Surveillance According to Specialty and Continent
Ibtissam Acem, Merel M Smit, Cornelis Verhoef, et al.
Critical Reviews in Oncology/Hematology
|
April 6, 2024
Patient-reported outcomes in randomized clinical trials of systemic therapy for advanced soft tissue sarcomas in adults: A systematic review
Evelyne Roets, Winette van der Graaf, Bauke H G van Riet, et al.
BMJ Open
|
November 2, 2023
(Cost-)effectiveness of an individualised risk prediction tool (PERSARC) on patient's knowledge and decisional conflict among soft-tissue sarcomas patients: protocol for a parallel cluster randomised trial (the VALUE-PERSARC study)
Anouk A Kruiswijk, Michiel A J van de Sande, Rick L Haas, et al.
BMJ Open
|
September 11, 2020
PropAngio study protocol: a neoadjuvant trial on the efficacy of propranolol monotherapy in cutaneous angiosarcoma-a proof of principle study
Kimberley M Heinhuis, Nikki S IJzerman, Anne Miek Koenen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 21, 2021
Local control and postponement of systemic therapy after modest dose radiotherapy in oligometastatic myxoid liposarcomas
Jules Lansu, Winan J van Houdt, Kirsten van Langevelde, et al.
JCO Clinical Cancer Informatics
|
July 1, 2024
Improving Diagnosis and Care for Patients With Sarcoma: Do Real-World General Practitioners Data and Prospective Data Collections Have a Place Next to Clinical Trials?
Emily I Holthuis, Marianne J Heins, Winan J van Houdt, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 15, 2025
Long-term survival of participants in the PASART-1 and PASART-2 trials of neo-adjuvant pazopanib and radiotherapy in soft tissue sarcoma
Bauke H G Van Riet, Milan Van Meekeren, Marta Fiocco, et al.
Annals of Surgical Oncology
|
February 1, 2025
Risk-Prediction Models for Clinical Decision-Making in Sarcoma Care: An International Survey Among Soft-Tissue Sarcoma Clinicians
Anouk A Kruiswijk, Lisa A E Vlug, Ibtissam Acem, et al.
Cancers
|
May 31, 2020
RNA-Sequencing of Tumor-Educated Platelets, a Novel Biomarker for Blood-Based Sarcoma Diagnostics
Kimberley M Heinhuis, Sjors G J G In 't Veld, Govert Dwarshuis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 3, 2024
Understanding how a personalized risk prediction tool (VALUE-PERSARC) supports informed treatment decisions of soft-tissue sarcomas patients in daily clinical practice - A mixed methods study
Anouk A Kruiswijk, Ellen G Engelhardt, Lisa A E Vlug, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 57) with videos related to
Sort By:
Page
of 6
Annals of Surgical Oncology
|
May 10, 2021
Management of Soft Tissue Sarcomas in Extremities: Variation in Treatment Recommendations and Surveillance According to Specialty and Continent
Ibtissam Acem, Merel M Smit, Cornelis Verhoef, et al.
Critical Reviews in Oncology/Hematology
|
April 6, 2024
Patient-reported outcomes in randomized clinical trials of systemic therapy for advanced soft tissue sarcomas in adults: A systematic review
Evelyne Roets, Winette van der Graaf, Bauke H G van Riet, et al.
BMJ Open
|
November 2, 2023
(Cost-)effectiveness of an individualised risk prediction tool (PERSARC) on patient's knowledge and decisional conflict among soft-tissue sarcomas patients: protocol for a parallel cluster randomised trial (the VALUE-PERSARC study)
Anouk A Kruiswijk, Michiel A J van de Sande, Rick L Haas, et al.
BMJ Open
|
September 11, 2020
PropAngio study protocol: a neoadjuvant trial on the efficacy of propranolol monotherapy in cutaneous angiosarcoma-a proof of principle study
Kimberley M Heinhuis, Nikki S IJzerman, Anne Miek Koenen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 21, 2021
Local control and postponement of systemic therapy after modest dose radiotherapy in oligometastatic myxoid liposarcomas
Jules Lansu, Winan J van Houdt, Kirsten van Langevelde, et al.
JCO Clinical Cancer Informatics
|
July 1, 2024
Improving Diagnosis and Care for Patients With Sarcoma: Do Real-World General Practitioners Data and Prospective Data Collections Have a Place Next to Clinical Trials?
Emily I Holthuis, Marianne J Heins, Winan J van Houdt, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 15, 2025
Long-term survival of participants in the PASART-1 and PASART-2 trials of neo-adjuvant pazopanib and radiotherapy in soft tissue sarcoma
Bauke H G Van Riet, Milan Van Meekeren, Marta Fiocco, et al.
Annals of Surgical Oncology
|
February 1, 2025
Risk-Prediction Models for Clinical Decision-Making in Sarcoma Care: An International Survey Among Soft-Tissue Sarcoma Clinicians
Anouk A Kruiswijk, Lisa A E Vlug, Ibtissam Acem, et al.
Cancers
|
May 31, 2020
RNA-Sequencing of Tumor-Educated Platelets, a Novel Biomarker for Blood-Based Sarcoma Diagnostics
Kimberley M Heinhuis, Sjors G J G In 't Veld, Govert Dwarshuis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 3, 2024
Understanding how a personalized risk prediction tool (VALUE-PERSARC) supports informed treatment decisions of soft-tissue sarcomas patients in daily clinical practice - A mixed methods study
Anouk A Kruiswijk, Ellen G Engelhardt, Lisa A E Vlug, et al.
Page
of 6